Peter Sagan marks brief return to road racing in Tour de Hongrie - Cyclingnews |
Peter Sagan marks brief return to road racing in Tour de Hongrie Cyclingnews
|
TIME100 Health: Peter Marks | TIME - TIME |
TIME100 Health: Peter Marks | TIME TIME
|
FDA's Peter Marks shares more on CAR-T secondary cancer probe - Fierce Pharma |
FDA's Peter Marks shares more on CAR-T secondary cancer probe Fierce Pharma
|
FDA's Peter Marks seems inclined to grant full approval to Sarepta's Duchenne gene therapy - STAT |
FDA's Peter Marks seems inclined to grant full approval to Sarepta's Duchenne gene therapy STAT
|
Peter Marks, Signing Off From His Post - americantheatre.org |
Peter Marks, Signing Off From His Post americantheatre.org
|
'We're open for business': FDA's Peter Marks says agency ready to review novel cancer vaccines despite unknowns - Fierce Biotech |
'We're open for business': FDA's Peter Marks says agency ready to review novel cancer vaccines despite unknowns Fierce Biotech
|
?I?m Not Dead Yet!?: Peter Marks on Covering DC Theater, Leaving the Post, and What?s Next - Washingtonian |
?I?m Not Dead Yet!?: Peter Marks on Covering DC Theater, Leaving the Post, and What?s Next Washingtonian
|
Theatre Critic Peter Marks to Leave Washington Post - Playbill |
Theatre Critic Peter Marks to Leave Washington Post Playbill
|
Perspective | A theater critic says so long, farewell, auf Wiedersehen, adieu - The Washington Post |
Perspective | A theater critic says so long, farewell, auf Wiedersehen, adieu The Washington Post
|
Peter Marks is gone
Now what? - DC Theater Arts |
Peter Marks is gone
Now what? DC Theater Arts
|
FDA?s Marks Advocates for Flexibility in Rare Disease Gene Therapy Trials - BioSpace |
FDA?s Marks Advocates for Flexibility in Rare Disease Gene Therapy Trials BioSpace
|
Marks discusses CAR-Ts, CRISPR and START at regenerative medicine meeting - Regulatory Affairs Professionals Society | RAPS |
Marks discusses CAR-Ts, CRISPR and START at regenerative medicine meeting Regulatory Affairs Professionals Society | RAPS
|
Peter Marks talks Operation Warp Speed for Rare Diseases - STAT |
Peter Marks talks Operation Warp Speed for Rare Diseases STAT
|
FDA's Peter Marks says gene editing breakthroughs have met regulatory reality - Fierce Biotech |
FDA's Peter Marks says gene editing breakthroughs have met regulatory reality Fierce Biotech
|
One Reason Theatre Is in Crisis: The Slow Death of Criticism - americantheatre.org |
One Reason Theatre Is in Crisis: The Slow Death of Criticism americantheatre.org
|
Marks talks OTP staffing, gene therapies, and more - Regulatory Affairs Professionals Society | RAPS |
Marks talks OTP staffing, gene therapies, and more Regulatory Affairs Professionals Society | RAPS
|
FDA CBER Chief Marks overrules staff drug reviewers 'with trepidation' - Fierce Biotech |
FDA CBER Chief Marks overrules staff drug reviewers 'with trepidation' Fierce Biotech
|
Peter Marks of the FDA named to STATUS List 2024 - STAT |
Peter Marks of the FDA named to STATUS List 2024 STAT
|
FDA's Peter Marks doesn't plan to retire soon?Chutes & Ladders - Fierce Biotech |
FDA's Peter Marks doesn't plan to retire soon?Chutes & Ladders Fierce Biotech
|
Official: FDA needs staff influx to meet gene therapy needs - STAT |
Official: FDA needs staff influx to meet gene therapy needs STAT
|
Best theater 2023: ?Merrily We Roll Along? and ?Spamalot? make the top 10 - The Washington Post |
Best theater 2023: ?Merrily We Roll Along? and ?Spamalot? make the top 10 The Washington Post
|
FDA eyes collaborative review pilot for gene therapies - Regulatory Affairs Professionals Society | RAPS |
FDA eyes collaborative review pilot for gene therapies Regulatory Affairs Professionals Society | RAPS
|
FDA's Marks went against reviewers' call on Sarepta's Elevidys - Fierce Pharma |
FDA's Marks went against reviewers' call on Sarepta's Elevidys Fierce Pharma
|
FDA's Pepaxto Decider: Peter Marks To Handle Oncopeptides' Appeal Of Accelerated Approval Withdrawal - Pink Sheet |
FDA's Pepaxto Decider: Peter Marks To Handle Oncopeptides' Appeal Of Accelerated Approval Withdrawal Pink Sheet
|
FDA?s Marks says global dialogue on gene therapy regulation key for patient access - Pharmaceutical Technology |
FDA?s Marks says global dialogue on gene therapy regulation key for patient access Pharmaceutical Technology
|
Peter Marks Obituary (2024) - San Rafael, CA - Marin Independent Journal - Legacy.com |
Peter Marks Obituary (2024) - San Rafael, CA - Marin Independent Journal Legacy.com
|
Peter Marks Obituary (1947 - 2024) - Belen, NM - Legacy.com |
Peter Marks Obituary (1947 - 2024) - Belen, NM Legacy.com
|
CAR-T Development In Autoimmune Should Continue, FDA's Marks Says; Malignancy Reports Not 'Overly Concerning' - Pink Sheet |
CAR-T Development In Autoimmune Should Continue, FDA's Marks Says; Malignancy Reports Not 'Overly Concerning' Pink Sheet
|
Accelerated Approval Now Starting Point For Gene Therapy Development, US FDA's Marks Says - Pink Sheet |
Accelerated Approval Now Starting Point For Gene Therapy Development, US FDA's Marks Says Pink Sheet
|
Pryzm nightclub boss blames lack of students for closures - BBC |
Pryzm nightclub boss blames lack of students for closures BBC
|
Elevidys' Age-Restricted Indication Not Negotiable, CBER's Peter Marks Told Sarepta - Pink Sheet |
Elevidys' Age-Restricted Indication Not Negotiable, CBER's Peter Marks Told Sarepta Pink Sheet
|
Review | 'Here We Are' brings Sondheim back to us
Just not as a raging success
- The Washington Post |
Review | 'Here We Are' brings Sondheim back to us
Just not as a raging success. The Washington Post
|
Hearing Wrap Up: Americans Deserve Improved Vaccine Injury and Compensation Systems - United States House ..
- oversight.house.gov |
Hearing Wrap Up: Americans Deserve Improved Vaccine Injury and Compensation Systems - United States House ... oversight.house.gov
|
FDA's Marks wants more quick approvals for rare disease drugs - Fierce Biotech |
FDA's Marks wants more quick approvals for rare disease drugs Fierce Biotech
|
Review | The best play of the year is David Adjmi's shattering 'Stereophonic' - The Washington Post |
Review | The best play of the year is David Adjmi's shattering 'Stereophonic' The Washington Post
|
Theatre Critic Peter Marks Will Depart the Washington Post - BroadwayWorld |
Theatre Critic Peter Marks Will Depart the Washington Post BroadwayWorld
|
Email Trove From US FDA Shows Peter Marks As Champion For Plasma Authorization - Pink Sheet |
Email Trove From US FDA Shows Peter Marks As Champion For Plasma Authorization Pink Sheet
|
Review | 'Merrily We Roll Along' gets the stunning Broadway revival it deserves - The Washington Post |
Review | 'Merrily We Roll Along' gets the stunning Broadway revival it deserves The Washington Post
|
Review | Oh, Barry
Manilow's overly earnest 'Harmony' arrives on Broadway
- The Washington Post |
Review | Oh, Barry
Manilow's overly earnest 'Harmony' arrives on Broadway. The Washington Post
|
Wenstrup Investigates FDA's Rushed Approval of the COVID-19 Vaccine - United States House Committee on ..
- oversight.house.gov |
Wenstrup Investigates FDA's Rushed Approval of the COVID-19 Vaccine - United States House Committee on ... oversight.house.gov
|
Opinion | Readers critique The Post: Goodbye, Dave Barry and so many other favorites - The Washington Post |
Opinion | Readers critique The Post: Goodbye, Dave Barry and so many other favorites The Washington Post
|
In play after play, artists keep asking the Jewish question to which there is no answer - Forward |
In play after play, artists keep asking the Jewish question to which there is no answer Forward
|
Review | A 'Ragtime' revival percolates with musical verve at Signature Theatre - The Washington Post |
Review | A 'Ragtime' revival percolates with musical verve at Signature Theatre The Washington Post
|
FDA Approves CRISPR Gene Therapy for Sickle Cell Disease - National Press Foundation |
FDA Approves CRISPR Gene Therapy for Sickle Cell Disease National Press Foundation
|
Review | 'Gutenberg!': A 'bad' musical done right by Josh Gad and Andrew Rannells - The Washington Post |
Review | 'Gutenberg!': A 'bad' musical done right by Josh Gad and Andrew Rannells The Washington Post
|
CBER Director Marks' Intervention On Sarepta Gene Therapy Filing Decision Appears To Backfire - Pink Sheet |
CBER Director Marks' Intervention On Sarepta Gene Therapy Filing Decision Appears To Backfire Pink Sheet
|
Review | Stand back, Washington
'Evita' has never been more thrilling
- The Washington Post |
Review | Stand back, Washington
'Evita' has never been more thrilling. The Washington Post
|
Review | In new D.C
play, Zelensky and Putin meet their match in an irate Mama - The Washington Post |
Review | In new D.C
play, Zelensky and Putin meet their match in an irate Mama The Washington Post
|
Lawmakers Clash Over COVID Vaccine Safety at House Hearing - Medpage Today |
Lawmakers Clash Over COVID Vaccine Safety at House Hearing Medpage Today
|
The year of gene therapy? FDA's Marks calls for solutions to regulatory, manufacturing challenges - bioworld.com |
The year of gene therapy? FDA's Marks calls for solutions to regulatory, manufacturing challenges bioworld.com
|
How is the cost-of-living crisis affecting nightclubs? - morningadvertiser.co.uk |
How is the cost-of-living crisis affecting nightclubs? morningadvertiser.co.uk
|
This Week at FDA: Marks testifies on vaccine safety, FDA approves new drugs for frostbite, allergic reactions, and more - Regulatory Affairs Professionals Society | RAPS |
This Week at FDA: Marks testifies on vaccine safety, FDA approves new drugs for frostbite, allergic reactions, and more Regulatory Affairs Professionals Society | RAPS
|
'Fat Ham,' 'Ragtime' and a Broadway-bound 'The Wiz' are on fall stages - The Washington Post - The Washington Post |
'Fat Ham,' 'Ragtime' and a Broadway-bound 'The Wiz' are on fall stages - The Washington Post The Washington Post
|
Review | The Alicia Keys musical, 'Hell's Kitchen,' is nice, and nothing more - The Washington Post |
Review | The Alicia Keys musical, 'Hell's Kitchen,' is nice, and nothing more The Washington Post
|
Review | 'Purlie Victorious' with Leslie Odom Jr
laughs wryly at racism - The Washington Post |
Review | 'Purlie Victorious' with Leslie Odom Jr
laughs wryly at racism The Washington Post
|
Peter Marks | International Research Development - bristol.ac.uk |
Peter Marks | International Research Development bristol.ac.uk
|
US FDA's Marks Was Frustrated About Slow Completion Of 2021 Comirnaty Review - Pink Sheet |
US FDA's Marks Was Frustrated About Slow Completion Of 2021 Comirnaty Review Pink Sheet
|
Review | In Jocelyn Bioh's sparkling new show, hair braiding is irresistible art - The Washington Post |
Review | In Jocelyn Bioh's sparkling new show, hair braiding is irresistible art The Washington Post
|
FDA investigates 'serious risk' of secondary cancer following CAR-T treatment - Fierce Pharma |
FDA investigates 'serious risk' of secondary cancer following CAR-T treatment Fierce Pharma
|
FDA Official Blasts Ladapo's Claims About DNA Fragments in COVID Shots - Medpage Today |
FDA Official Blasts Ladapo's Claims About DNA Fragments in COVID Shots Medpage Today
|
Sliding Scale: Bar For COVID Therapeutics EUAs 'Can Be Somewhat Variable' ? FDA's Peter Marks - Pink Sheet |
Sliding Scale: Bar For COVID Therapeutics EUAs 'Can Be Somewhat Variable' ? FDA's Peter Marks Pink Sheet
|
Rekom UK sold for £19.5m - morningadvertiser.co.uk |
Rekom UK sold for £19.5m morningadvertiser.co.uk
|
Review | 'Danny and the Deep Blue Sea' with Aubrey Plaza hits some rough waters - The Washington Post |
Review | 'Danny and the Deep Blue Sea' with Aubrey Plaza hits some rough waters The Washington Post
|
Review | Even relatable Danny DeVito can't rescue this play about a hoarder - The Washington Post |
Review | Even relatable Danny DeVito can't rescue this play about a hoarder The Washington Post
|
Review | Woolly Mammoth's 'Public Obscenities' is long on insight
Also, long
- The Washington Post |
Review | Woolly Mammoth's 'Public Obscenities' is long on insight
Also, long. The Washington Post
|
Peter Mark Honours Staff In Tralee For Long-Standing Service - traleetoday.ie - traleetoday.ie |
Peter Mark Honours Staff In Tralee For Long-Standing Service - traleetoday.ie traleetoday.ie
|
The theater world hasn't recovered from the pandemic and is in crisis - The Washington Post |
The theater world hasn't recovered from the pandemic and is in crisis The Washington Post
|
STAT@JPM: What's Next in Biotech? - STAT - STAT |
STAT@JPM: What's Next in Biotech? - STAT STAT
|
Review | Melissa Etheridge is giving fans a piece of her heart on Broadway - The Washington Post |
Review | Melissa Etheridge is giving fans a piece of her heart on Broadway The Washington Post
|
Denbighshire trailer maker Peter celebrates his 50th anniversary on the line - denbighshirefreepress.co.uk |
Denbighshire trailer maker Peter celebrates his 50th anniversary on the line denbighshirefreepress.co.uk
|
Review | Don't throw a shoe: David Byrne's 'Here Lies Love' gives Imelda sizzle - The Washington Post |
Review | Don't throw a shoe: David Byrne's 'Here Lies Love' gives Imelda sizzle The Washington Post
|
Neverending story ? Inside Story - insidestory.org.au |
Neverending story ? Inside Story insidestory.org.au
|
FDA's Marks weighs in on adcomm reform - Regulatory Affairs Professionals Society | RAPS |
FDA's Marks weighs in on adcomm reform Regulatory Affairs Professionals Society | RAPS
|
Welcome to Professor Peter Marks from the University of Sydney - bristol.ac.uk |
Welcome to Professor Peter Marks from the University of Sydney bristol.ac.uk
|
VAERS: A Critical Part of the National Vaccine Safety System - Food and Drug Administration (.gov) |
VAERS: A Critical Part of the National Vaccine Safety System Food and Drug Administration (.gov)
|
Perspective | In anti-drag Texas, 'The Rocky Horror Show' is now a political act - The Washington Post |
Perspective | In anti-drag Texas, 'The Rocky Horror Show' is now a political act The Washington Post
|
Blue Peter marks 65th birthday with Prince William - Prolific North |
Blue Peter marks 65th birthday with Prince William Prolific North
|
Review | A comic goes undercover with bigots
You'll want to hear how it went
- The Washington Post |
Review | A comic goes undercover with bigots
You'll want to hear how it went. The Washington Post
|
Review | Kelli O'Hara and Brian d'Arcy James soar in 'Days of Wine and Roses' - The Washington Post |
Review | Kelli O'Hara and Brian d'Arcy James soar in 'Days of Wine and Roses' The Washington Post
|
The self-fashioning of George Orwell ? Inside Story - insidestory.org.au |
The self-fashioning of George Orwell ? Inside Story insidestory.org.au
|
Bill Bradley was an NBA star and a senator
Now he's a one-man show
- The Washington Post |
Bill Bradley was an NBA star and a senator
Now he's a one-man show. The Washington Post
|
FDA 'Leans In' to Accelerated Approval for Rare Disease Drugs - Medpage Today |
FDA 'Leans In' to Accelerated Approval for Rare Disease Drugs Medpage Today
|
Broadway's 'Grey House' is a near-miss at scaring you out of your wits - The Washington Post - The Washington Post |
Broadway's 'Grey House' is a near-miss at scaring you out of your wits - The Washington Post The Washington Post
|
Turning Gene Therapy Into Reality: Peter Marks, MD, PhD - Neurology live |
Turning Gene Therapy Into Reality: Peter Marks, MD, PhD Neurology live
|
A top F.D.A
official moved on Monday to take over the agency's vaccines office
(Published 2021) - The New York Times |
A top F.D.A
official moved on Monday to take over the agency's vaccines office
(Published 2021) The New York Times
|
FDA's Peter Marks, M.D., Ph.D
to deliver Keynote Address at 2023 Muscular Dystrophy Association Clinical & Scientific ..
- CEMDA |
FDA's Peter Marks, M.D., Ph.D
to deliver Keynote Address at 2023 Muscular Dystrophy Association Clinical & Scientific ... CEMDA
|
Behind the historic US vaccine effort is FDA's Peter Marks
The job is 'not for the faint of heart.' - USA TODAY |
Behind the historic US vaccine effort is FDA's Peter Marks
The job is 'not for the faint of heart.' USA TODAY
|
Obituary: Dr
Peter A
Marks, 60, of Guilford - Patch |
Obituary: Dr
Peter A
Marks, 60, of Guilford Patch
|
An Interview with the FDA's Peter Marks - The Medicine Maker |
An Interview with the FDA's Peter Marks The Medicine Maker
|
Peter Marks Outlines FDA's Commitment to Gene Therapies - Genetic Engineering & Biotechnology News |
Peter Marks Outlines FDA's Commitment to Gene Therapies Genetic Engineering & Biotechnology News
|
Top FDA official: Agency needs to start using accelerated approval for gene therapies - STAT |
Top FDA official: Agency needs to start using accelerated approval for gene therapies STAT
|
Peter Marks Prioritizing Better Communication And Faster Product Reviews - lifescienceleader.com |
Peter Marks Prioritizing Better Communication And Faster Product Reviews lifescienceleader.com
|
FDA's Peter Marks on Covid-19, priorities, and gene, cell therapy reviews - STAT |
FDA's Peter Marks on Covid-19, priorities, and gene, cell therapy reviews STAT
|
FDA official offers insights into whether gene therapy makers could use common manufacturing process - STAT |
FDA official offers insights into whether gene therapy makers could use common manufacturing process STAT
|
Washington Post Theatre Critic Peter Marks Goes Private on Twitter After Conservative Criticism of Downstate Review - Playbill |
Washington Post Theatre Critic Peter Marks Goes Private on Twitter After Conservative Criticism of Downstate Review Playbill
|
FDA's Peter Marks will 'call the balls and strikes' on coronavirus vaccine - The Washington Post |
FDA's Peter Marks will 'call the balls and strikes' on coronavirus vaccine The Washington Post
|
Orthobiologics; podcast with Dr
Peter Marks - news.sanfordhealth.org |
Orthobiologics; podcast with Dr
Peter Marks news.sanfordhealth.org
|
How ?Schmigadoon!? season two made this critic a super fan - The Washington Post |
How ?Schmigadoon!? season two made this critic a super fan The Washington Post
|
• © Esto es El Cine 2024